Adipokines mediate inflammation and insulin resistance

Frontiers in Endocrinology

Volumn 4, Issue JUN, 2013, Pages

  Kwon, Hyokjoon ^a   Pessin, Jeffrey E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adipocyte; Adipokine; Inflammation; Insulin; Macrophages; Metabolism

Indexed keywords

ADIPOCYTOKINE; ANGIOPOIETIN 2; APELIN; CHEMERIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OMENTIN 1; PROTEIN KINASE B; RANTES; RESISTIN; RETINOL BINDING PROTEIN 4; SECRETED FRIZZLED RELATED PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASPIN;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONSHIVERING THERMOGENESIS; OBESITY; REVIEW; WHITE ADIPOSE TISSUE;

EID: 84880974817     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00071     Document Type: Review

References (147)

1. Akbay, E., Muslu, N., Nayir, E., Ozhan, O., and Kiykim, A. (2010). Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes. J. Endocrinol. Invest. 33, 725-729. doi:10.3275/7024
2. Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., et al. (2009). Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206, 249-258. doi:10.1084/jem.20080129
3. Aleffi, S., Petrai, I., Bertolani, C., Parola, M., Colombatto, S., Novo, E., et al. (2005). Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42, 1339-1348. doi:10.1002/hep.20965
4. Ashcroft, F. M., and Rorsman, P. (2012). Diabetes mellitus and the beta cell: the last ten years. Cell 148, 1160-1171. doi:10.1016/j.cell.2012.02.010
5. Badin, P. M., Vila, I. K., Louche, K., Mairal, A., Marques, M. A., Bourlier, V., et al. (2013). High-fat diet-mediated lipotoxicity and insulin resistance is related to impaired lipase expression in mouse skeletal muscle. Endocrinology 154, 1444-1453. doi:10.1210/en.2012-2029
6. Bard-Chapeau, E. A., Hevener, A. L., Long, S., Zhang, E. E., Olefsky, J. M., and Feng, G. S. (2005). Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action. Nat. Med. 11, 567-571. doi:10.1038/nm1227
7. Bendelac, A., Savage, P. B., and Teyton, L. (2007). The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336. doi:10.1146/annurev.immunol.25.022106.141711 CrossRef Full Text
8. Benomar, Y., Gertler, A., de Lacy, P., Crepin, D., Hamouda, H. O., Riffault, L., et al. (2013). Central resistin overexposure induces insulin resistance through toll-like receptor 4. Diabetes 62, 102-114. doi:10.2337/db12-0237
9. Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V., Duffaut, C., Bonnafous, S., et al. (2012). Identification of adipose tissue dendritic cells correlated with obesityassociated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 61, 2238-2247. doi:10.2337/db11-1274
10. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., and Tarkowski, A. (2005). Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174, 5789- 5795.
11. Bondue, B., Wittamer, V., and Parmentier, M. (2011). Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev. 22, 331-338. doi:10.1016/j.cytogfr.2011.11.004
12. Boura-Halfon, S., and Zick, Y. (2009). Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296, E581-E591. doi:10.1152/ajpendo.90437.2008
13. Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., and Butler, P. C. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110. doi:10.2337/diabetes.52.1.102
14. Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., et al. (2006). Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554-1561. doi:10.2337/db06-0133
15. Carpene, C., Dray, C., Attane, C., Valet, P., Portillo, M. P., Churruca, I., et al. (2007). Expanding role for the apelin/APJ system in physiopathology. J. Physiol. Biochem. 63, 359-373. doi:10.1007/BF03165767
16. Cash, J. L., Hart, R., Russ, A., Dixon, J. P., Colledge, W. H., Doran, J., et al. (2008). Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775. doi:10.1084/jem.20071601
17. Chavez, J. A., and Summers, S. A. (2012). A ceramide-centric view of insulin resistance. Cell Metab. 15, 585-594. doi:10.1016/j.cmet.2012.04.002
18. Chiefari, E., Tanyolac, S., Paonessa, F., Pullinger, C. R., Capula, C., Iiritano, S., et al. (2011). Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305, 903-912. doi:10.1001/jama.2011.207
19. Chin, J. E., Liu, F., and Roth, R. A. (1994). Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol. Endocrinol. 8, 51-58. doi:10.1210/me.8.1.51
20. Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R., et al. (1987). Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 237, 402-405. doi:10.1126/science.3299705
21. Cornier, M. A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., et al. (2008). The metabolic syndrome. Endocr. Rev. 29, 777-822. doi:10.1210/er.2008-0024 CrossRef Full Text
22. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789. doi:10.1038/378785a0
23. Day, R. T., Cavaglieri, R. C., and Feliers, D. (2013). Apelin retards the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 304, F788-F800. doi:10.1152/ajprenal.00306.2012
24. de Souza Batista, C. M., Yang, R. Z., Lee, M. J., Glynn, N. M., Yu, D. Z., Pray, J., et al. (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56, 1655-1661. doi:10.2337/db06-1506 CrossRef Full Text
25. Deng, J., Liu, Y., Yang, M., Wang, S., Zhang, M., Wang, X., et al. (2012). Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 64, 3564-3573. doi:10.1002/art.34637
26. Dinarello, C. A. (2009). Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550. doi:10.1146/annurev.immunol.021908.132612
27. Donath, M. Y., Gross, D. J., Cerasi, E., and Kaiser, N. (1999). Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48, 738-744. doi:10.2337/diabetes.48.4.738 CrossRef Full Text
28. Ehses, J. A., Lacraz, G., Giroix, M. H., Schmidlin, F., Coulaud, J., Kassis, N., et al. (2009). IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Natl. Acad. Sci. U.S.A. 106, 13998-14003. doi:10.1073/pnas.0810087106
29. Elgazar-Carmon, V., Rudich, A., Hadad, N., and Levy, R. (2008). Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J. Lipid Res. 49, 1894-1903. doi:10.1194/jlr.M800132-JLR200
30. Ernst, M. C., Issa, M., Goralski, K. B., and Sinal, C. J. (2010). Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151, 1998-2007. doi:10.1210/en.2009-1098
31. Faggioni, R., Jones-Carson, J., Reed, D. A., Dinarello, C. A., Feingold, K. R., Grunfeld, C., et al. (2000). Leptin-deficient (ob/ob) mice are protected from T cellmediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc. Natl. Acad. Sci. U.S.A. 97, 2367-2372. doi:10.1073/pnas.040561297
32. Farjo, K. M., Farjo, R. A., Halsey, S., Moiseyev, G., and Ma, J. X. (2012). Retinol-binding protein 4 induces inflammation in human endothelial cells by a NADPH oxidase- and nuclear factor kappa b-dependent and retinol-independent mechanism. Mol. Cell. Biol. 32, 5103-5115. doi:10.1128/MCB.00820-12
33. Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., and Mingrone, G. (1997). Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J. Clin. Invest. 100, 1166-1173. doi:10.1172/JCI119628
34. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., et al. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939. doi:10.1038/nm.2002
35. Finkelstein, E. A., Khavjou, O. A., Thompson, H., Trogdon, J. G., Pan, L., Sherry, B., et al. (2012). Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42, 563-570. doi:10.1016/j.amepre.2011.10.026
36. Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., and Klein, S. (2007). Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010-1013. doi:10.2337/db06-1656
37. Friedman, J. M., and Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763-770. doi:10.1038/27376
38. Gabrielsen, J. S., Gao, Y., Simcox, J. A., Huang, J., Thorup, D., Jones, D., et al. (2012). Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest. 122, 3529-3540. doi:10.1172/JCI44421
39. Gainsford, T., Willson, T. A., Metcalf, D., Handman, E., McFarlane, C., Ng, A., et al. (1996). Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 93, 14564-14568. doi:10.1073/pnas.93.25.14564
40. Gan, L., Guo, K., Cremona, M. L., McGraw, T. E., Leibel, R. L., and Zhang, Y. (2012). TNF-alpha up-regulates protein level and cell surface expression of the leptin receptor by stimulating its export via a PKC-dependent mechanism. Endocrinology 153, 5821-5833. doi:10.1210/en.2012-1510
41. Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., and Eckhardt, E. (2009). Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50, 90- 97. doi:10.1194/jlr.M800156-JLR200
42. Goldfine, A. B., Conlin, P. R., Halperin, F., Koska, J., Permana, P., Schwenke, D., et al. (2013). A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia 56, 714-723. doi:10.1007/s00125-012-2819-3
43. Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., and Shoelson, S. E. (2010). The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346-357. doi:10.1059/0003-4819-152-6-201003160-00004
44. Gonzalez-Gay, M. A., de Matias, J. M., Gonzalez-Juanatey, C., Garcia-Porrua, C., Sanchez-Andrade, A., Martin, J., et al. (2006). Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24, 83-86.
45. Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., Parlee, S. D., et al. (2007). Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 28175-28188. doi:10.1074/jbc.M700793200
46. Graham, T. E., Yang, Q., Bluher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., et al. (2006). Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354, 2552-2563. doi:10.1056/NEJMoa054862
47. Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., et al. (1999). Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48, 1270-1274. doi:10.2337/diabetes.48.6.1270
48. Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., et al. (1996). Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97, 2152-2157. doi:10.1172/JCI118653
49. Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., et al. (2006). Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737. doi:10.1126/science.1123965
50. Hardy, O. T., Czech, M. P., and Corvera, S. (2012). What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes Obes. 19, 81-87. doi:10.1097/MED.0b013e3283514e13
51. Hegele, R. A. (2003). Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome. Trends Endocrinol. Metab. 14, 371-377. doi:10.1016/S1043-2760(03)00142-5
52. Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., and Seida, A. (2005). Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. U.S.A. 102, 10610-10615. doi:10.1073/pnas.0504703102
53. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333- 336. doi:10.1038/nature01137
54. Holcomb, I. N., Kabakoff, R. C., Chan, B., Baker, T. W., Gurney, A., Henzel, W., et al. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4055. doi:10.1093/emboj/19.15.4046
55. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867. doi:10.1038/nature05485
56. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668. doi:10.1126/science.271.5249.665
57. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91. doi:10.1126/science.7678183
58. Jornayvaz, F. R., and Shulman, G. I. (2012). Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab. 15, 574-584. doi:10.1016/j.cmet.2012.03.005
59. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., et al. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505. doi:10.1172/JCI26498
60. Karelis, A. D., Faraj, M., Bastard, J. P., St-Pierre, D. H., Brochu, M., Prud'homme, D., et al. (2005). The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 90, 4145-4150. doi:10.1210/jc.2005-0482
61. Kievit, P., Howard, J. K., Badman, M. K., Balthasar, N., Coppari, R., Mori, H., et al. (2006). Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 4, 123-132. doi:10.1016/j.cmet.2006.06.010
62. Kim, D. H., Sandoval, D., Reed, J. A., Matter, E. K., Tolod, E. G., Woods, S. C., et al. (2008). The role of GM-CSF in adipose tissue inflammation. Am. J. Physiol. Endocrinol. Metab. 295, E1038-E1046. doi:10.1152/ajpendo.00061.2008
63. Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., et al. (2007a). Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100, 1589-1596. doi:10.1161/CIRCRESAHA.106.142851
64. Kim, J. Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., et al. (2007b). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621-2637. doi:10.1172/JCI31021
65. Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D., and Heinecke, J. W. (2008). Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 57, 1254-1261. doi:10.2337/db07-1061
66. Kitade, H., Sawamoto, K., Nagashimada, M., Inoue, H., Yamamoto, Y., Sai, Y., et al. (2012). CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61, 1680-1690. doi:10.2337/db11-1506
67. Kleinridders, A., Schenten, D., Konner, A. C., Belgardt, B. F., Mauer, J., Okamura, T., et al. (2009). MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10, 249-259. doi:10.1016/j.cmet.2009.08.013
68. Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., et al. (2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109, 2046-2049. doi:10.1161/01.CIR.0000127953.98131.ED
69. Kursawe, R., Caprio, S., Giannini, C., Narayan, D., Lin, A., D'adamo, E., et al. (2013). Decreased transcription of ChREBP-alpha/beta isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 62, 837 -844. doi:10.2337/db12-0889
70. Lee, J. Y., Sohn, K. H., Rhee, S. H., and Hwang, D. (2001). Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689. doi:10.1074/jbc.M011695200
71. Li, S., Shin, H. J., Ding, E. L., and Van Dam, R. M. (2009). Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179- 188. doi:10.1001/jama.2009.976
72. Liu, J., Divoux, A., Sun, J., Zhang, J., Clement, K., Glickman, J. N., et al. (2009). Genetic deficiency and pharmacological stabilization of mast cells reduce dietinduced obesity and diabetes in mice. Nat. Med. 15, 940-945. doi:10.1038/nm.1994
73. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., and Lechler, R. I. (1998). Leptin modulates the T-cell immune response and reverses starvationinduced immunosuppression. Nature 394, 897-901. doi:10.1038/29795
74. Lu, Y., Zhu, X., Liang, G. X., Cui, R. R., Liu, Y., Wu, S. S., et al. (2012). Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-kappaB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 43, 2125-2136. doi:10.1007/s00726-012-1298-7
75. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007a). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184. doi:10.1172/JCI29881
76. Lumeng, C. N., Deyoung, S. M., Bodzin, J. L., and Saltiel, A. R. (2007b). Increased inflammatory properties of adipose tissue macrophages recruited during dietinduced obesity. Diabetes 56, 16-23. doi:10.2337/db06-1076
77. Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., et al. (2012). Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37, 574-587. doi:10.1016/j.immuni.2012.06.016
78. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731-737. doi:10.1038/nm724
79. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., et al. (2001). PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099. doi:10.2337/diabetes.50.9.2094
80. Mantell, B. S., Stefanovic-Racic, M., Yang, X., Dedousis, N., Sipula, I. J., and O'Doherty, R. M. (2011). Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS ONE 6:e19831. doi:10.1371/journal.pone.0019831
81. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. doi:10.1016/j.it.2004.09.015
82. Martinez, F. O., Helming, L., and Gordon, S. (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451- 483. doi:10.1146/annurev.immunol.021908.132532
83. Matarese, G., di Giacomo, A., Sanna, V., Lord, G. M., Howard, J. K., Di Tuoro, A., et al. (2001). Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166, 5909-5916.
84. Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H., Henstridge, D. C., Watson, N., et al. (2010). Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53, 2431-2441. doi:10.1007/s00125-010-1865-y
85. Monteiro, M., Almeida, C. F., Agua-Doce, A., and Graca, L. (2013). Induced IL-17-producing invariant NKT cells require activation in presence of TGF-beta and IL- 1beta. J. Immunol. 190, 805-811. doi:10.4049/jimmunol.1201010
86. Mori, H., Prestwich, T. C., Reid, M. A., Longo, K. A., Gerin, I., Cawthorn, W. P., et al. (2012). Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J. Clin. Invest. 122, 2405-2416. doi:10.1172/JCI63604
87. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969. doi:10.1038/nri2448
88. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., et al. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920. doi:10.1038/nm.1964
89. Odegaard, J. I., and Chawla, A. (2013). Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339, 172-177. doi:10.1126/science.1230721
90. Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., and Taylor, R. (1996). Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45, 881-885. doi:10.2337/diabetes.45.7.881
91. Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., et al. (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106, 2767-2770. doi:10.1161/01.CIR.0000042707.50032.19
92. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., et al. (2010). Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457. doi:10.1126/science.1188280
93. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97. doi:10.1038/nri2921
94. Ozcan, L., Ergin, A. S., Lu, A., Chung, J., Sarkar, S., Nie, D., et al. (2009). Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35-51. doi:10.1016/j.cmet.2008.12.004
95. Pessin, J. E., and Saltiel, A. R. (2000). Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 106, 165-169. doi:10.1172/JCI10582
96. Phalitakul, S., Okada, M., Hara, Y., and Yamawaki, H. (2011). Vaspin prevents TNF-alpha-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-kappaB and PKCtheta activation in cultured rat vascular smooth muscle cells. Pharmacol. Res. 64, 493-500. doi:10.1016/j.phrs.2011.06.001
97. Qi, Y., Nie, Z., Lee, Y. S., Singhal, N. S., Scherer, P. E., Lazar, M. A., et al. (2006). Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55, 3083-3090. doi:10.2337/db05-0615
98. Quan, W., Kim, H. K., Moon, E. Y., Kim, S. S., Choi, C. S., Komatsu, M., et al. (2012). Role of hypothalamic proopiomelanocortin neuron autophagy in the control of appetite and leptin response. Endocrinology 153, 1817-1826. doi:10.1210/en.2011-1882
99. Ravussin, E., and Galgani, J. E. (2011). The implication of brown adipose tissue for humans. Annu. Rev. Nutr. 31, 33-47. doi:10.1146/annurev-nutr-072610-145209
100. Reilly, S. M., Chiang, S. H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., et al. (2013). An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nat. Med. 19, 313-321. doi:10.1038/nm.3082
101. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and White, M. F. (2002). SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394-42398. doi:10.1074/jbc.C200444200
102. Samuel, V. T., and Shulman, G. I. (2012). Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871. doi:10.1016/j.cell.2012.02.017
103. Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., and Maedler, K. (2008). The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149, 2208-2218. doi:10.1210/en.2007-1059
104. Savkur, R. S., Philips, A. V., and Cooper, T. A. (2001). Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40-47. doi:10.1038/ng704
105. Schaffler, A., Neumeier, M., Herfarth, H., Furst, A., Scholmerich, J., and Buchler, C. (2005). Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta 1732, 96-102. doi:10.1016/j.bbaexp.2005.11.005
106. Schenk, S., Saberi, M., and Olefsky, J. M. (2008). Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002. doi:10.1172/JCI34260
107. Schipper, H. S., Rakhshandehroo, M., van de Graaf, S. F., Venken, K., Koppen, A., Stienstra, R., et al. (2012). Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest. 122, 3343-3354. doi:10.1172/JCI62739
108. Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., et al. (2003). Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746. doi:10.1074/jbc.M210689200
109. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., and Flier, J. S. (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025. doi:10.1172/JCI28898
110. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y., Brown, M. S., and Goldstein, J. L. (2000). Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86. doi:10.1016/S1097-2765(00)00009-5
111. Shoelson, S. E., Lee, J., and Goldfine, A. B. (2006). Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801. doi:10.1172/JCI29069
112. Souza, S. C., de Vargas, L. M., Yamamoto, M. T., Lien, P., Franciosa, M. D., Moss, L. G., et al. (1998). Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 273, 24665-24669. doi:10.1074/jbc.273.38.24665
113. Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817. doi:10.2337/diabetes.52.3.812
114. Stanley, T. L., Zanni, M. V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., et al. (2011). TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E146-E150. doi:10.1210/jc.2010-1170
115. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., et al. (2001). The hormone resistin links obesity to diabetes. Nature 409, 307-312. doi:10.1038/35053000
116. Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., and Lazar, M. A. (2005). Activation of SOCS-3 by resistin. Mol. Cell. Biol. 25, 1569-1575. doi:10.1128/MCB.25.4.1569-1575.2005
117. Stienstra, R., Tack, C. J., Kanneganti, T. D., Joosten, L. A., and Netea, M. G. (2012). The inflammasome puts obesity in the danger zone. Cell Metab. 15, 10-18. doi:10.1016/j.cmet.2011.10.011
118. Tabata, M., Kadomatsu, T., Fukuhara, S., Miyata, K., Ito, Y., Endo, M., et al. (2009). Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 10, 178-188. doi:10.1016/j.cmet.2009.08.003
119. Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M. T., Summer, R. S., et al. (2007). Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest. 117, 375-386. doi:10.1172/JCI29709
120. Talukdar, S., Oh, D. Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., et al. (2012). Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 18, 1407-1412. doi:10.1038/nm.2885
121. Tan, B. K., Adya, R., Farhatullah, S., Chen, J., Lehnert, H., and Randeva, H. S. (2010). Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59, 3023-3031. doi:10.2337/db10-0124
122. Taniguchi, C. M., Emanuelli, B., and Kahn, C. R. (2006). Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96. doi:10.1038/nrm1837
123. Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M. X., et al. (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251, 471-476. doi:10.1006/bbrc.1998.9489
124. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., and Hotamisligil, G. S. (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614. doi:10.1038/39335
125. Waki, H., and Tontonoz, P. (2007). Endocrine functions of adipose tissue. Annu. Rev. Pathol. 2, 31-56. doi:10.1146/annurev.pathol.2.010506.091859
126. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S. L., et al. (2002). Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75-79. doi:10.1038/nm0102-75
127. Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., et al. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124. doi:10.1172/JCI24335C1
128. Wilk, S., Jenke, A., Stehr, J., Yang, C. A., Bauer, S., Goldner, K., et al. (2013). Adiponectin modulates NK-cell function. Eur. J. Immunol. 43, 1024-1033. doi:10.1002/eji.201242382
129. Wilk, S., Scheibenbogen, C., Bauer, S., Jenke, A., Rother, M., Guerreiro, M., et al. (2011). Adiponectin is a negative regulator of antigen-activated T cells. Eur. J. Immunol. 41, 2323-2332. doi:10.1002/eji.201041349
130. Winer, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., et al. (2011). B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610-617. doi:10.1038/nm.2353
131. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., et al. (2009a). Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921-929. doi:10.1038/nm.2001
132. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., et al. (2009b). Obesity predisposes to Th17 bias. Eur. J. Immunol. 39, 2629-2635. doi:10.1002/eji.200838893
133. Wittamer, V., Franssen, J. D., Vulcano, M., Mirjolet, J. F., Le Poul, E., Migeotte, I., et al. (2003). Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977-985. doi:10.1084/jem.20030382
134. Wu, D., Molofsky, A. B., Liang, H. E., Ricardo-Gonzalez, R. R., Jouihan, H. A., Bando, J. K., et al. (2011). Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243-247. doi:10.1126/science.1201475
135. Wu, J., Bostrom, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A. H., et al. (2012a). Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376. doi:10.1016/j.cell.2012.05.016
136. Wu, L., Parekh, V. V., Gabriel, C. L., Bracy, D. P., Marks-Shulman, P. A., Tamboli, R. A., et al. (2012b). Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc. Natl. Acad. Sci. U.S.A. 109, E1143-E1152. doi:10.1073/pnas.1200498109
137. Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S., and Cooper, G. J. (2003). The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91-100. doi:10.1172/JCI17797
138. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295. doi:10.1038/nm788
139. Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., et al. (2005). Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362. doi:10.1038/nature03711
140. Yang, R. Z., Lee, M. J., Hu, H., Pray, J., Wu, H. B., Hansen, B. C., et al. (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 290, E1253-E1261. doi:10.1152/ajpendo.00572.2004
141. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., et al. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723-1732.
142. Yue, P., Jin, H., Aillaud, M., Deng, A. C., Azuma, J., Asagami, T., et al. (2010). Apelin is necessary for the maintenance of insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 298, E59-E67. doi:10.1152/ajpendo.00385.2009
143. Yue, P., Jin, H., Xu, S., Aillaud, M., Deng, A. C., Azuma, J., et al. (2011). Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms. Endocrinology 152, 59-68. doi:10.1210/en.2010-0576
144. Zhang, H. H., Halbleib, M., Ahmad, F., Manganiello, V. C., and Greenberg, A. S. (2002). Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51, 2929-2935. doi:10.2337/diabetes.51.10.2929
145. Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H., and Cai, D. (2008). Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73. doi:10.1016/j.cell.2008.07.043
146. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi:10.1038/372425a0
147. Zheng, J. Y., Zou, J. J., Wang, W. Z., Feng, X. Y., Shi, Y. Y., Zhao, Y., et al. (2011). Tumor necrosis factor-alpha increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 339, 120-129. doi:10.1016/j.mce.2011.04.002